BOB1 increases the longevity of hematopoietic stem cells via up regulation of its target gene, Genome-2-Bio-Medicine Discovery Center, 07/July/2014, 7.49 am

MiRNAs-based therapy for Cardiovascular and metabolic disorders: MiRNA-25 improves cardiovascular and metabolic abnormalities via down regulation of its target gene, 7/July/2014, 7.34 am
July 7, 2014
Natural product-based therapy for Tuberculosis: Cirsiliol (3′,4′,5-trihydroxy-6,7-dimethoxyflavone), a flavone isolated from Achillea fragrantissima, inhibits the pathogenesis and progression of tuberculosis (Mtb) via up regulation of its target gene, 7/July/2014, 8.43 am
July 7, 2014
Show all

Noble laureate in Physiology/Medicine (1975) Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the journal Elife that “MiRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice.”

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: BOB1 increases the longevity of hematopoietic stem cells via up regulation of its target gene.  

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  BOB1 increases the longevity of hematopoietic stem cells via up regulation of its target gene,  Genome-2-Bio-Medicine Discovery Center, 07/July/2014, 7.49 am

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.